Impact of changes in conventional risk factors induced by once-weekly GLP-1 receptor agonist exenatide on cardiovascular outcomes: an EXSCEL post hoc analysis - Coleman, RL; Adler, AI; Mentz, RJ; Fudim, M; Sattar, N; Holman, RR (Cardiovascular Diabetology, 2025)